FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Animals (Basel) / Lidocaine’s Ineffectiveness in Mitigating Lipopolysacc...
Animals : an open access journal from MDPI2024; 14(21); 3147; doi: 10.3390/ani14213147

Lidocaine’s Ineffectiveness in Mitigating Lipopolysaccharide-Induced Pain and Peristaltic Effects in Horses.

Abstract: The present study involved seven horses in a randomized crossover clinical trial to evaluate the effect of lidocaine on horses with induced endotoxemia. Horses received intravenous lidocaine (1.5 mg/kg bolus, followed by 0.05 mg/kg bwt/min) or placebo (0.9% sodium chloride at the same manner) one hour before LPS administration (0.03 μg/kg, IV infusion over 30 min). We monitored clinic and hematologic parameters, abdominal auscultation, ultrasound, and pain over time. No relevant clinical differences existed between treatments regarding peristalsis, abdominal pain, or any other parameters before and after endotoxemia induction. These findings do not support the clinical use of lidocaine to mitigate abdominal pain and intestinal hypomotility promoted by endotoxemia in horses.
Get Full Text
Publication Date: 2024-11-02 PubMed ID: 39518869PubMed Central: PMC11545326DOI: 10.3390/ani14213147Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the ineffectiveness of lidocaine, a local anesthetic, in reducing pain and peristaltic effects in horses brought about by an endotoxic condition, a serious bacterial infection that can lead to systemic inflammation.

Study Design and Methodology

  • The author conducted a randomized crossover clinical trial involving seven horses. The cross-over design meant that the same horses were used in both the treatment and control groups, but at different times, thereby providing more reliable data.
  • The effect of lidocaine was evaluated by inducing endotoxemia in the horses. Endotoxemia is caused by the presence of a large quantity of endotoxins (harmful substances released when bacteria are destroyed) in the blood, which can lead to systemic inflammation and cause severe illness or death.
  • The horses were divided into groups and received either intravenous lidocaine (at a specific dosage) or a placebo (0.9% sodium chloride, also known as saline solution, given in the same fashion) one hour before LPS (lipopolysaccharide, a type of endotoxin) administration. LPS was used to mimic the bacterial infection in a controlled manner.

Monitoring and Evaluation

  • Following the administration of lidocaine or placebo and the induced endotoxemia, the researchers monitored clinical and hematologic parameters, abdominal auscultation (listening to the sounds within the abdomen), ultrasonographic images, and pain over time.
  • These parameters were monitored to understand the effect of lidocaine on common symptoms of endotoxemia in horses, such as changes in blood parameters, abdominal discomfort, and decreased peristaltic (digestive tract) movements.

Study Findings

  • The outcomes of the study revealed no significant clinical differences between treatments (i.e., between the lidocaine and placebo groups) regarding peristalsis (muscular contractions that move food through the digestive tract), abdominal pain or any other parameters before and after the induction of endotoxemia.
  • This lack of difference indicates that lidocaine, contrary to what one might suppose given its pain-relieving properties in other contexts, does not effectively mitigate abdominal pain and intestinal hypomotility (a condition wherein the movement of the food through the digestive tract slows down) promoted by endotoxemia in horses.

Implications

  • The conclusions drawn from this study suggest that lidocaine may not be an effective option for addressing abdominal pain and hypomotility in cases of endotoxemia in horses, thus informing potential future treatment decision-making in the veterinary field.
  • The absence of a strong effect of lidocaine on these symptoms could lead to further research into alternatives for the alleviation of endotoxemia-induced discomfort in horses.

Cite This Article

APA
Sousa LN, Winter IC, Varela DD, Luvison EZ, Guzmán JFC, Machado AMV, Figueiredo RDV, Pena GT, Dos Santos ACS, Faleiros RR, Carvalho AM. (2024). Lidocaine’s Ineffectiveness in Mitigating Lipopolysaccharide-Induced Pain and Peristaltic Effects in Horses. Animals (Basel), 14(21), 3147. https://doi.org/10.3390/ani14213147

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 14
Issue: 21
PII: 3147

Researcher Affiliations

Sousa, Lara Nunes
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Winter, Isabella Caixeta
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Varela, Diego Duarte
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Luvison, Eduarda Zancanaro
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Guzmán, Juan Felipe Colmenares
  • Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Machado, Ana Moutinho Vilella
  • Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Figueiredo, Renata Diniz Vilela
  • Veterinary Medicine, Pontifical Catholic University of Minas Gerais, Belo Horizonte 30140-002, Brazil.
Pena, Gabriel Tavares
  • Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Dos Santos, Ana Clara Silva
  • Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
Faleiros, Rafael Resende
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.
  • CNPq Research Fellow, National Council for Scientific and Technological Development (CNPq), Brasília 71605-001, Brazil.
Carvalho, Armando de Mattos
  • EQUINOVA Research Group, Department of Veterinary Medicine and Surgery, Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil.

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 31 references
  1. Moore JN, Barton MH. Treatment of endotoxemia. Vet. Clin. N. Am. Equine Pract. 2003;19:681–695.
    doi: 10.1016/j.cveq.2003.08.006pubmed: 14740763google scholar: lookup
  2. Holcombe SJ. Monitoring gastrointestinal function in the equine intensive care unit. Clin. Tech. Equine Pract. 2003;2:156–164.
    doi: 10.1016/S1534-7516(03)00028-3google scholar: lookup
  3. Wong DM, Davis JL, White NA. Motility of the equine gastrointestinal tract: Physiology and pharmacotherapy. Equine Vet. Educ. 2011;23:88–100.
    doi: 10.1111/j.2042-3292.2010.00173.xgoogle scholar: lookup
  4. Van Hoogmoed LM, Nieto JE, Snyder JR, Harmon FA. Survey of Prokinetic Use in Horses with Gastrointestinal Injury. Vet. Surg. 2004;33:279–285.
    doi: 10.1111/j.1532-950X.2004.04041.xpubmed: 15104636google scholar: lookup
  5. Okamura K, Sasaki N, Yamada M, Yamada H, Inokuma H. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility. Res. Vet. Sci. 2009;86:302–308.
    doi: 10.1016/j.rvsc.2008.07.008pubmed: 18723200google scholar: lookup
  6. Salem SE, Proudman CJ, Archer DC. Has intravenous lidocaine improved the outcome in horses following surgical management of small intestinal lesions in a UK hospital population?. BMC Vet. Res. 2016;12:157.
    doi: 10.1186/s12917-016-0784-7pmc: PMC4962447pubmed: 27459996google scholar: lookup
  7. Freeman DE. Is There Still a Place for Lidocaine in the (Postoperative) Management of Colics?. Vet. Clin. N. Am. Equine Pract. 2019;35:275–288.
    doi: 10.1016/j.cveq.2019.03.003pubmed: 31076222google scholar: lookup
  8. Robertson SA, Sanchez LC, Merritt AM, Doherty TJ. Effect of systemic lidocaine on visceral and somatic nociception in conscious horses. Equine Vet. J. 2005;37:122–127.
    doi: 10.2746/0425164054223723pubmed: 15779623google scholar: lookup
  9. Cook VL, Shults JJ, McDowell M, Campbell NB, Davis JL, Blikslager AT. Attenuation of ischaemic injury in the equine jejunum by administration of systemic lidocaine. Equine Vet. J. 2008;40:353–357.
    doi: 10.2746/042516408X293574pubmed: 18321812google scholar: lookup
  10. Rusiecki KE, Nieto JE, Puchalski SM, Snyder JR. Evaluation of Continuous Infusion of Lidocaine on Gastrointestinal Tract Function in Normal Horses. Vet. Surg. 2008;37:564–570.
    doi: 10.1111/j.1532-950X.2008.00421.xpubmed: 19134107google scholar: lookup
  11. Milligan M, Beard W, Kukanich B, Sobering T, Waxman S. The Effect of Lidocaine on Postoperative Jejunal Motility in Normal Horses. Vet. Surg. 2007;36:214–220.
    doi: 10.1111/j.1532-950X.2007.00255.xpubmed: 17461945google scholar: lookup
  12. Salciccia A, Arevalo ML, Maes A, Croubels S, Busoni V, Detilleux J, Sandersen C, Amory H. Cardiovascular, respiratory, gastrointestinal and behavioural effects of intravenous lidocaine administration in healthy horses in conscious and evaluation of the relationship with serum concentrations of lidocaine and monoethylglycine xylidide. Vlaams Diergeneeskd. Tijdschr. 2019;88:67–76.
    doi: 10.21825/vdt.v88i2.16027google scholar: lookup
  13. Boscan P, Van Hoogmoed LM, Farver TB, Snyder JR. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses. Am. J. Vet. Res. 2006;67:992–997.
    doi: 10.2460/ajvr.67.6.992pubmed: 16740092google scholar: lookup
  14. VanDierendonck MC, van Loon JP. Monitoring acute equine visceral pain with the Equine Utrecht University Scale for Composite Pain Assessment (EQUUS-COMPASS) and the Equine Utrecht University Scale for Facial Assessment of Pain (EQUUS-FAP): A validation study. Vet. J. 2016;216:175–177.
    doi: 10.1016/j.tvjl.2016.08.004pubmed: 27687948google scholar: lookup
  15. Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG. Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses. J. Vet. Pharmacol. Ther. 2012;35:413–416.
    doi: 10.1111/j.1365-2885.2011.01356.xpmc: PMC4219550pubmed: 22132770google scholar: lookup
  16. Valadao CA, Peiro JR, Santana AE, Bechara GH. Evaluation of peritoneal fluid in horses with experimental endotoxemia. J. Equine Vet. Sci. 1995;15:124–128.
    doi: 10.1016/S0737-0806(07)80448-5google scholar: lookup
  17. Holcombe SJ, Jacobs CC, Cook VL, Gandy JC, Hauptman JG, Sordillo LM. Duration of in vivo endotoxin tolerance in horses. Vet. Immunol. Immunopathol. 2016;173:10–16.
    doi: 10.1016/j.vetimm.2016.03.016pubmed: 27090620google scholar: lookup
  18. Oliveira-Filho JP, Badial PR, Cunha PHJ, Peiró JR, Araújo Junior JP, Divers TJ, Winand NJ, Borges AS. Lipopolysaccharide infusion up-regulates hepcidin mRNA expression in equine liver. Innate Immun. 2011;18:438–446.
    doi: 10.1177/1753425911420181pubmed: 21926164google scholar: lookup
  19. Urayama S, Tanaka A, Kusano K, Sato H, Nagashima T, Fukuda I, Fujisawa C, Matsuda H, Urayama S, Tanaka A. Oral Administration of Meloxicam Suppresses Low-Dose Endotoxin Challenge–Induced Pain in Thoroughbred Horses. J. Equine Vet. Sci. 2019;77:139–143.
    doi: 10.1016/j.jevs.2019.03.001pubmed: 31133308google scholar: lookup
  20. Garcia FJM, Cara CG, Aguilera-Aguilera R, Buzon-Cuevas A, Perez-Ecija A. Meloxicam ameliorates the systemic inflammatory response syndrome associated with experimentally induced endotoxemia in adult donkeys. J. Vet. Intern. Med. 2020;34:1631–1641.
    doi: 10.1111/jvim.15783pmc: PMC7379049pubmed: 32463537google scholar: lookup
  21. MacKay RJ, Lester GD. Induction of the acute-phase cytokine, hepatocyte-stimulating factor/interleukin 6, in the circulation of horses treated with endotoxin. Am. J. Vet. Res. 1992;53:1285–1289.
    doi: 10.2460/ajvr.1992.53.08.1285pubmed: 1510298google scholar: lookup
  22. Sykes B, Furr M. Equine endotoxaemia—A state-of-the-art review of therapy. Aust. Vet. J. 2005;83:45–50.
    doi: 10.1111/j.1751-0813.2005.tb12191.xpubmed: 15971817google scholar: lookup
  23. Rosa P, Peiró J, Campebell R, Valadão C, Bechara G. Effects of diclofenac and dexamethasone on horse experimental endotoxemia. Arq. Bras. Med. Vet. E Zootec. 2003;55:279–286.
    doi: 10.1590/S0102-09352003000300006google scholar: lookup
  24. King JN, Gerring EL. Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone. Equine Colic 1989;21:38–42.
    doi: 10.1111/j.2042-3306.1989.tb05653.xpubmed: 9118104google scholar: lookup
  25. Peiró JR, Barnabé PA, Cadioli FA, Cunha FQ, Lima VHF, Mendonça VH, Santana AE, Malheiros EB, Perri SHV, Valadão CAA. Effects of Lidocaine Infusion during Experimental Endotoxemia in Horses. J. Vet. Intern. Med. 2010;24:940–948.
    doi: 10.1111/j.1939-1676.2010.0555.xpubmed: 20649751google scholar: lookup
  26. Brianceau P, Chevalier H, Karas A, Court MH, Bassage L, Kirker-Head C, Provost P, Paradis MR. Intravenous Lidocaine and Small-Intestinal Size, Abdominal Fluid, and Outcome after Colic Surgery in Horses. J. Vet. Intern. Med. 2002;16:736–741.
    doi: 10.1892/0891-6640(2002)016<0736:ilassa>2.3.co;2pubmed: 12465774google scholar: lookup
  27. Van Weyenberg S, Sales J, Janssens G. Passage rate of digesta through the equine gastrointestinal tract: A review. Livest. Sci. 2006;99:3–12.
    doi: 10.1016/j.livprodsci.2005.04.008google scholar: lookup
  28. Moore JN, Garner HE, Shapland JE, Hatfield DG. Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Vet. J. 1981;13:95–98.
    doi: 10.1111/j.2042-3306.1981.tb04122.xpubmed: 7018898google scholar: lookup
  29. Malone E, Ensink J, Turner T, Wilson J, Andrews F, Keegan K, Lumsden J. Intravenous Continuous Infusion of Lidocaine for Treatment of Equine Ileus. Vet. Surg. 2006;35:60–66.
    doi: 10.1111/j.1532-950X.2005.00113.xpubmed: 16409411google scholar: lookup
  30. Koenig J, Cote N. Equine gastrointestinal motility—Ileus and pharmacological modification. Can. Vet. J. 2006 47:551–559.
    pmc: PMC1461410pubmed: 16808227
  31. Williams JM, Lin YJ, Loftus JP, Faleiros RR, Peroni JF, Hubbell JAE, Ravis WR, Belknap JK. Effect of intravenous lidocaine administration on laminar inflammation in the black walnut extract model of laminitis. Equine Vet. J. 2010;42:261–269.
    doi: 10.2746/042516409X475760pubmed: 20486984google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.